Hormone Replacement Therapy for Perimenopause: Benefits, Risks, and When to Start

Hormone replacement therapy, or HRT, can help perimenopause symptoms like hot flashes, night sweats, poor sleep, and vaginal dryness by replacing declining estrogen, with progesterone added if you still have a uterus. For many healthy women, starting before age 60 or within 10 years of menopause has the most favorable benefit-risk balance 1.

What is perimenopause, and why do hormone levels matter?

Perimenopause is the menopause transition, when ovarian hormone patterns become less predictable. It can start years before the final menstrual period, and symptoms often come from changing estrogen and progesterone signals rather than a simple steady decline 1.

How estrogen and progesterone shift before menopause

Estrogen, especially estrogen (estradiol), can swing up and down during perimenopause. Progesterone may fall earlier when ovulation becomes less regular. This mismatch can cause heavy or irregular bleeding, breast tenderness, sleep disruption, and mood changes in some people 1.

Common symptoms: hot flashes, night sweats, sleep, mood, vaginal dryness

The most common HRT-related symptoms are vasomotor symptoms: hot flashes and night sweats. Low estrogen can also contribute to genitourinary syndrome of menopause, which includes vaginal dryness, pain with sex, urinary urgency, and recurrent urinary symptoms 1.

• Hot flashes or night sweats that disrupt work, sleep, or daily life
• Waking often at night, especially with sweating or heat surges
• Vaginal dryness, burning, or pain with sex
• Urinary urgency or recurrent urinary discomfort after other causes are checked
• Irregular, heavy, or unpredictable periods that need medical evaluation before assuming they are hormonal

What is hormone replacement therapy?

Hormone replacement therapy uses estrogen, with or without a progestogen, to relieve symptoms caused by changing hormone levels. It is also called menopausal hormone therapy, or MHT, because it is used during the menopause transition and after menopause 1.

Estrogen-only vs. estrogen plus progestogen

Estrogen-only therapy may be used after hysterectomy. If you still have a uterus, estrogen is usually paired with progesterone or another progestogen because unopposed estrogen can thicken the uterine lining and raise endometrial cancer risk 2.

Common estrogen options include estradiol and conjugated equine estrogens, such as Premarin. Progestogen is the umbrella term for progesterone and synthetic progestins. The right choice depends on symptoms, uterus status, bleeding pattern, migraine history, clot risk, cancer history, and personal preference 2.

Systemic vs. local vaginal therapy

Systemic HRT reaches the whole body and is used for hot flashes, night sweats, and broader symptoms. Local vaginal estrogen acts mainly in vaginal and urinary tissues and is often used for genitourinary syndrome of menopause when hot flashes are not the main issue 1.

What forms does HRT come in?

HRT forms include pills, patches, gels, sprays, vaginal rings, creams, tablets, and sometimes an intrauterine device for progestin support. Route matters: oral estrogen goes through the liver first, while transdermal estrogen enters through the skin and may have a different clot-risk profile 3.

What age should you start HRT for perimenopause?

Starting HRT is less about a single age and more about symptoms, menstrual stage, and health history. The Menopause Society states that for healthy symptomatic women younger than 60 or within 10 years of menopause, the benefit-risk ratio is generally favorable 1.

The timing hypothesis and the 10-year window

The timing hypothesis means that HRT risk may differ depending on how close a person is to menopause. In the ELITE randomized trial, oral estradiol was linked with slower carotid artery thickening when started less than 6 years after menopause, but not when started 10 or more years after menopause 4.

This does not mean everyone should start HRT early. It means timing is one part of the evaluation, along with blood pressure, migraine with aura, smoking, clot history, cancer history, uterine bleeding, and personal goals 1.

Early or premature menopause considerations

People with early menopause, before age 45, or premature ovarian insufficiency, before age 40, may have different needs. Professional guidance often supports hormone therapy until the average age of menopause when there are no contraindications, because early estrogen loss is linked with bone and cardiovascular concerns 1.

What are the benefits of HRT in perimenopause?

HRT benefits are strongest for hot flashes and night sweats. It can also help vaginal and urinary symptoms when the right route is used, and it can prevent bone loss while a person is taking it; these benefits must be weighed against clot, stroke, gallbladder, breast, and uterine risks 1.

Vasomotor symptom relief

Systemic estrogen therapy is the most effective treatment for vasomotor symptoms in many guidelines. A Cochrane review found hormone therapy reduced hot flash frequency and severity compared with placebo, although side effects such as breast tenderness, bleeding, nausea, and headache can occur 5.

Genitourinary symptoms and sexual health

For vaginal dryness, burning, pain with sex, and urinary symptoms related to genitourinary syndrome of menopause, low-dose vaginal estrogen is a common option. Local therapy is often preferred when symptoms are mainly vaginal or urinary and systemic hot flashes are not the main concern 1.

Bone protection and osteoporosis prevention

Systemic estrogen helps prevent bone loss and can reduce fracture risk while it is used. In the Women’s Health Initiative, estrogen plus progestin reduced hip fracture risk but also increased risks including breast cancer, stroke, pulmonary embolism, and coronary heart disease in the studied population, so individual risk matters 6.

What are the risks and side effects of HRT?

HRT risks depend on age, time since menopause, route, dose, personal history, and whether estrogen is combined with a progestogen. Side effects can include breast tenderness, bloating, nausea, headache, mood changes, sleepiness, spotting, and irregular bleeding 2.

Blood clots, stroke, and gallbladder disease

Oral estrogen can increase liver production of clotting factors, which is one reason route matters. ACOG notes that orally administered estrogen may have a prothrombotic effect, while transdermal estrogen appears to have less effect on clotting markers in available evidence 3.

The Women’s Health Initiative estrogen-plus-progestin trial found increased risk of stroke and pulmonary embolism in the studied group, which had an average age of 63 at enrollment. That age matters because WHI was not mainly a trial of newly perimenopausal women seeking symptom relief 6.

Breast and endometrial cancer context

Breast cancer risk differs by formulation, duration, and whether progestogen is used. WHI reported increased invasive breast cancer risk with combined conjugated equine estrogen plus medroxyprogesterone acetate, while estrogen-only results differed in people without a uterus 6, 7.

Endometrial cancer risk is a different issue. If a person has a uterus, systemic estrogen without enough progestogen can stimulate the uterine lining; this is why estrogen plus progesterone or another progestogen is commonly used 2.

Updated FDA boxed warning guidance

In 2025, FDA announced updates to labeling language for menopausal hormone therapies, including removal of boxed-warning language about cardiovascular disease, breast cancer, and probable dementia for certain products, while keeping safety information in labeling 8. Labels still matter, and clinicians still screen for risk before prescribing.

Who should not take HRT?

HRT is not appropriate for some people, and it may require specialist input for others. Most guidelines advise avoiding systemic HRT in people with known or suspected breast cancer, estrogen-dependent cancer, unexplained vaginal bleeding, active or past blood clots, stroke, heart attack, active liver disease, or pregnancy 2.

• Personal history of breast cancer or another hormone-sensitive cancer, unless a specialist advises otherwise
• Known or suspected endometrial cancer
• Unexplained vaginal bleeding that has not been evaluated
• Prior stroke, heart attack, pulmonary embolism, deep vein thrombosis, or known high-risk clotting disorder
• Active liver disease
• Pregnancy or possible pregnancy
• Very high cardiovascular risk, which needs individualized review

Heavy bleeding, bleeding after sex, bleeding after menopause, pelvic pain, or new anemia should be evaluated before starting HRT. Perimenopause is common, but not every bleeding change is caused by hormones 2.

What should you know about bioidentical and compounded hormone therapy?

Bioidentical hormones are hormones with the same chemical structure as hormones made by the body, such as estradiol and progesterone. Some are FDA-approved products, and some are compounded by 503A pharmacies for an individual prescription 9.

FDA-approved bioidentical options

The word bioidentical does not automatically mean compounded. FDA-approved estradiol and micronized progesterone products exist, and they have labeling, manufacturing standards, and FDA-reviewed safety and efficacy data for their approved uses 9.

How compounded HRT is prepared and regulated

Compounded HRT is prepared for an individual prescription by a compounding pharmacy, such as a state-licensed 503A pharmacy. Compounded medications are not FDA-approved, which means FDA does not review them for safety, effectiveness, or quality before they are dispensed 10.

ACOG guidance

ACOG’s 2023 Clinical Consensus states that compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations are available, and that patients should be counseled about the lack of FDA approval and potential risks specific to compounding 9.

At Chia, we take that counseling seriously. Our role is to review your history, explain trade-offs in plain language, and prescribe only when our licensed provider believes a treatment fits your clinical picture.

How does getting evaluated for HRT at Chia work?

Chia’s HRT for Women protocol is one online path for patients whose symptoms and health history fit treatment. The protocol includes oral estradiol plus progesterone IR, meaning immediate-release progesterone, after review by a licensed US provider through our HRT for Women protocol.

Our online clinical review process

You start with a short online health questionnaire, then a licensed provider reviews your symptoms, medical history, medications, contraindications, and goals. A prescription is never guaranteed, and some patients need in-person testing, imaging, labs, or specialist care before HRT is safe to consider.

The HRT for Women protocol

If you want to see whether Chia may be a fit, you can begin with the online eligibility quiz. Between visits, patients can message their care team through the patient portal.

When Chia may not be the right fit

Chia may not be the right starting point if you have unexplained vaginal bleeding, a complex cancer history, a recent blood clot, stroke, heart attack, active liver disease, pregnancy, or symptoms that need urgent in-person care. In those cases, specialist or local evaluation comes first 2.

How long should you stay on HRT, and how do you stop?

How long to stay on HRT depends on symptom control, risks, age, and personal goals. The Menopause Society does not require routine stopping at a set age; instead, it supports periodic re-evaluation of benefits and risks with shared decision-making 1.

Some people use HRT for a few years during the most intense vasomotor symptoms. Others continue longer for persistent symptoms or bone-related reasons. The key is a regular check-in, not an automatic stop date 1.

Stopping can be done suddenly or by tapering, but symptoms may return either way. A clinician can help plan timing, monitor bleeding, adjust non-hormonal supports, and reassess whether local vaginal estrogen, non-hormonal hot flash treatments, or bone-health care is needed 2.

Is HRT worth it for perimenopause?

HRT can be worth it when symptoms are meaningfully affecting sleep, work, mood, sex, or quality of life and your health history supports a favorable risk profile. It is not a wellness shortcut; it is a medical treatment with real benefits and real risks 1.

A good HRT visit should answer five questions: What symptoms are we treating? Do you still have a uterus? Which route fits your risks? What side effects should we watch for? When will we reassess? That is the same practical frame our providers use when reviewing HRT requests at Chia.

Frequently asked questions

Keep reading

Peptides

Kisspeptin-10: How It Works, Uses, and What the Research Says

Peptides

Best Peptides for Women: An Evidence-Based Guide by Goal

Peptides

Kisspeptin Peptide: What It Does, Evidence, Risks, and Access